Abstract
Platelet adhesion to subendothelial matrices and cohesion to other platelets is essential for hemostasis, but recent studies have revealed that platelet adhesive interactions may also generate cross-talk with other cell types, including leukocytes, tumor cells, and microbial pathogens. In so doing, these adhesive interactions may impact a variety of protective or disease-promoting processes, and they are mediated by platelet adhesion receptors from several gene families, most notably integrins, as exemplified by the platelet-restricted integrin, αIIbβ3. During hemostasis, multiple brakes and controls on platelet adhesion receptors prevent pathological thrombosis. Thus, threshold levels of excitatory stimuli must be surpassed and sufficient to drive intracellular signaling for full activation of integrin receptors. Stimuli for primary hemostasis derive from released or generated soluble agonists, vascular matrices exposed by vessel injury, or by hydrodynamic shear stress. While the non-integrin adhesion receptor, GPIb-V-IX, is critical for platelet adhesion to matrix von Willebrand factor (VWF) during hemostasis and is a mediator of platelet aggregation through interactions with VWF at pathologically high shear stresses in atherosclerotic arteries, finely regulated interactions of αIIbβ3 with fibrinogen and other Arg-Gly-Asp (RGD)-containing ligands are required for platelet aggregation in hemostatic thrombi. In this chapter we present an overview of classical and nonclassical regulation of platelet adhesion receptors and associated signaling pathways, with a principle focus on platelet signaling pathways that converge on and regulate αIIbβ3.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Tamimi M, Tan CW, Qiao J, Pennings GJ, Javadzadegan A, Yong AS, Arthur JF, Davis AK, Jing J, Mu FT, Hamilton JR, Jackson SP, Ludwig A, Berndt MC, Ward CM, Kritharides L, Andrews RK, Gardiner EE (2012) Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels. Blood 119:4311–4320
Andre P, Delaney SM, LaRocca T, Vincent D, DeGuzman F, Jurek M, Koller B, Phillips DR, Conley PB (2003) P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 112:398–406
Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, Kerrigan SW, Watson SP (2014) Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood 123:3166–3174
Arthur JF, Dunkley S, Andrews RK (2007) Platelet glycoprotein VI-related clinical defects. Br J Haematol 139:363–372
Asselin J, Gibbins JM, Achison M, Lee YH, Morton LF, Farndale RW, Barnes MJ, Watson SP (1997) A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1. Blood 89:1235–1242
Bennett JS (2015) Regulation of integrins in platelets. Biopolymers 104:323–333
Bennett JS, Vilaire G (1979) Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64:1393–1401
Bennett JS, Chan C, Vilaire G, Mousa SA, DeGrado WF (1997) Agonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem 272:8137–8140
Bergmeier W, Stefanini L (2013) Platelet ITAM signaling. Curr Opin Hematol 20:445–450
Bergmeier W, Piffath CL, Goerge T, Cifuni SM, Ruggeri ZM, Ware J, Wagner DD (2006) The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci U S A 103:16900–16905
Bertagnolli ME, Locke SJ, Hensler ME, Bray PF, Beckerle MC (1993) Talin distribution and phosphorylation in thrombin-activated platelets. J Cell Sci 106:1189–1199
Beumer S, IJsseldijk MJ, de Groot PG, Sixma JJ (1994) Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Blood 84:3724–3733
Bialkowska K, Zaffran Y, Meyer SC, Fox JE (2003) 14-3-3 Zeta mediates integrin-induced activation of Cdc42 and Rac. Platelet glycoprotein Ib-IX regulates integrin-induced signaling by sequestering 14-3-3 zeta. J Biol Chem 278:33342–33350
Blenner MA, Dong X, Springer TA (2014) Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib. J Biol Chem 289:5565–5579
Boilard E, Pare G, Rousseau M, Cloutier N, Dubuc I, Levesque T, Borgeat P, Flamand L (2014) Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation. Blood 123:2854–2863
Borst O, Munzer P, Gatidis S, Schmidt EM, Schonberger T, Schmid E, Towhid ST, Stellos K, Seizer P, May AE et al (2012) The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res 111:1297–1307
Bouvard D, Pouwels J, De Franceschi N, Ivaska J (2013) Integrin inactivators: balancing cellular functions in vitro and in vivo. Nat Rev Mol Cell Biol 14:430–442
Brass LF, Joseph SK (1985) A role for inositol triphosphate in intracellular Ca2+ mobilization and granule secretion in platelets. J Biol Chem 260:15172–15179
Brass LF, Tomaiuolo M, Stalker TJ (2013) Harnessing the platelet signaling network to produce an optimal hemostatic response. Hematol Oncol Clin North Am 27:381–409
Braun A, Varga-Szabo D, Kleinschnitz C, Pleines I, Bender M, Austinat M, Bosl M, Stoll G, Nieswandt B (2009) Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 113:2056–2063
Braun A, Vogtle T, Varga-Szabo D, Nieswandt B (2011) STIM and Orai in hemostasis and thrombosis. Front Biosci (Landmark Ed) 16:2144–2160
Bryckaert M, Rosa JP, Denis CV, Lenting PJ (2015) Of von Willebrand factor and platelets. Cell Mol Life Sci 72:307–326
Buensuceso CS, Obergfell A, Soriani A, Eto K, Kiosses WB, Arias-Salgado EG, Kawakami T, Shattil SJ (2005) Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta. J Biol Chem 280:644–653
Canault M, Ghalloussi D, Grosdidier C, Guinier M, Perret C, Chelghoum N, Germain M, Raslova H, Peiretti F, Morange PE et al (2014) Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med 211:1349–1362
Canobbio I, Bertoni A, Lova P, Paganini S, Hirsch E, Sinigaglia F, Balduini C, Torti M (2001) Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc gamma IIA receptor. J Biol Chem 276:26022–26029
Carestia A, Rivadeneyra L, Romaniuk MA, Fondevila C, Negrotto S, Schattner M (2013) Functional responses and molecular mechanisms involved in histone-mediated platelet activation. Thromb Haemost 110:1035–1045
Cattaneo M (2011) The platelet P2Y(1)(2) receptor for adenosine diphosphate: congenital and drug-induced defects. Blood 117:2102–2112
Cattaneo M (2015) P2Y12 receptors: structure and function. J Thromb Haemost 13(Suppl 1):S10–S16
Cattaneo M, Gachet C (1999) ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 19:2281–2285
Chang YC, Zhang H, Franco-Barraza J, Brennan ML, Patel T, Cukierman E, Wu J (2014) Structural and mechanistic insights into the recruitment of talin by RIAM in integrin signaling. Structure 22:1810–1820
Chrzanowska-Wodnicka M, Smyth SS, Schoenwaelder SM, Fischer TH, White GC (2005) Rap1b is required for normal platelet function and hemostasis in mice. J Clin Investig 115:680–687
Cifuni SM, Wagner DD, Bergmeier W (2008) CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood 112:1696–1703
Coller BS (2015) alphaIIbbeta3: Structure and function. J Thromb Haemost 13(Suppl 1):S17–S25
Coller BS, Shattil SJ (2008) The GP IIb/IIIa (integrin αIIbβ3) odyssey: a technology driven saga of a receptor with twists, turns and even a bend. Blood 112:3011–3025
Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800–1814
Cox D, Kerrigan SW, Watson SP (2011) Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 9:1097–1107
Cranmer SL, Ashworth KJ, Yao Y, Berndt MC, Ruggeri ZM, Andrews RK, Jackson SP (2011) High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbalpha-filamin interaction. Blood 117:2718–2727
Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, Housman DE, Graybiel AM (2004) CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 10:982–986
Crosby D, Poole AW (2003) Physical and functional interaction between protein kinase C delta and Fyn tyrosine kinase in human platelets. J Biol Chem 278:24533–24541
Dangelmaier C, Manne BK, Liverani E, Jin J, Bray P, Kunapuli SP (2014) PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses. Thromb Haemost 111:508–517
De Ceunynck K, De Meyer SF, Vanhoorelbeke K (2013) Unwinding the von Willebrand factor strings puzzle. Blood 121:270–277
de Stoppelaar SF, van’t Veer C, van der Poll T (2014) The role of platelets in sepsis. Thromb Haemost 112:666–677
Dong JF, Sae-Tung G, Lopez JA (1997) Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site. Blood 89:4355–4363
Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, Ajzenberg N, Grandchamp B, Jandrot-Perrus M (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114:1900–1903
Echtler K, Stark K, Lorenz M, Kerstan S, Walch A, Jennen L, Rudelius M, Seidl S, Kremmer E, Emambokus NR et al (2010) Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16:75–82
Ehlers R, Ustinov V, Chen Z, Zhang X, Rao R, Luscinskas FW, Lopez J, Plow E, Simon DI (2003) Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha. J Exp Med 198:1077–1088
Elsaraj SM, Bhullar RP (2008) Regulation of platelet Rac1 and Cdc42 activation through interaction with calmodulin. Biochim Biophys Acta 1783:770–778
Eto K, Murphy R, Kerrigan SW, Bertoni A, Stuhlmann H, Nakano T, Leavitt AD, Shattil SJ (2002) Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A 99:12819–12824
Etzioni A (2014) Leukocyte adhesion deficiency III—when integrins activation fails. J Clin Immunol 34:900–903
Falati S, Edmead CE, Poole AW (1999) Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets. Blood 94:1648–1656
Felding-Habermann B, Cheresh DA (1993) Vitronectin and its receptors. Curr Opin Cell Biol 5:864–868
Feng C, Li YF, Yau YH, Lee HS, Tang XY, Xue ZH, Zhou YC, Lim WM, Cornvik TC, Ruedl C et al (2012) Kindlin-3 mediates integrin alphaLbeta2 outside-in signaling, and it interacts with scaffold protein receptor for activated-C kinase 1 (RACK1). J Biol Chem 287:10714–10726
Francischetti IM, Saliou B, Leduc M, Carlini CR, Hatmi M, Randon J, Faili A, Bon C (1997) Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets. Toxicon 35:1217–1228
Franco AT, Corken A, Ware J (2015) Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126:582–588
Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107:15880–15885
Furie B, Flaumenhaft R (2014) Thiol isomerases in thrombus formation. Circ Res 114:1162–1173
Garcia-Alvarez B, de Pereda JM, Calderwood DA, Ulmer TS, Critchley D, Campbell ID, Ginsberg MH, Liddington RC (2003) Structural determinants of integrin recognition by talin. Mol Cell 11:49–58
Gardiner EE, Andrews RK (2014) Structure and function of platelet receptors initiating blood clotting. Adv Exp Med Biol 844:263–275
Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC (2007) Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 5:1530–1537
Gawaz M, Vogel S, Pfannenberg C, Pichler B, Langer H, Bigalke B (2014) Implications of glycoprotein VI for theranostics. Thromb Haemost 112:26–31
Geberhiwot T, Ingerpuu S, Pedraza C, Neira M, Lehto U, Virtanen I, Kortesmaa J, Tryggvason K, Engvall E, Patarroyo M (1999) Blood platelets contain and secrete laminin-8 (alpha4beta1gamma1) and adhere to laminin-8 via alpha6beta1 integrin. Exp Cell Res 253:723–732
Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MA, Stegner D, van der Meijden PE, Kuijpers MJ, Varga-Szabo D, Heemskerk JW, Nieswandt B (2010) Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 285:23629–23638
Ginsberg MH (2014) Integrin activation. BMB Rep 47:655–659
Gloerich M, Bos JL (2011) Regulating Rap small G-proteins in time and space. Trends Cell Biol 21:615–623
Golebiewska EM, Poole AW (2015) Platelet secretion: from haemostasis to wound healing and beyond. Blood Rev 29:153–162
Gong H, Shen B, Flevaris P, Chow C, Lam SC, Voyno-Yasenetskaya TA, Kozasa T, Du X (2010) G protein subunit Galpha13 binds to integrin alphaIIbbeta3 and mediates integrin “outside-in” signaling. Science 327:340–343
Grassle S, Huck V, Pappelbaum KI, Gorzelanny C, Aponte-Santamaria C, Baldauf C, Grater F, Schneppenheim R, Obser T, Schneider SW (2014) von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. Arterioscler Thromb Vasc Biol 34:1382–1389
Guidetti GF, Canobbio I, Torti M (2015) PI3K/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul 59:36–52
Gupta N, Li W, Willard B, Silverstein RL, McIntyre TM (2014) Proteasome proteolysis supports stimulated platelet function and thrombosis. Arterioscler Thromb Vasc Biol 34:160–168
Gurbel PA, Kuliopulos A, Tantry US (2015) G-protein-coupled receptors signaling pathways in new antiplatelet drug development. Arterioscler Thromb Vasc Biol 35:500–512
Haling JR, Monkley SJ, Critchley DR, Petrich BG (2011) Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood 117:1719–1722
Hall KJ, Jones ML, Poole AW (2007) Coincident regulation of PKCdelta in human platelets by phosphorylation of Tyr311 and Tyr565 and phospholipase C signalling. Biochem J 406:501–509
Hamamy H, Makrythanasis P, Al-Allawi N, Muhsin AA, Antonarakis SE (2014) Recessive thrombocytopenia likely due to a homozygous pathogenic variant in the FYB gene: case report. BMC Med Genet 15:135
Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O (2015) Platelets and infections—complex interactions with bacteria. Front Immunol 6:82
Han J, Lim CJ, Watanabe N, Soriani A, Ratnikov B, Calderwood DA, Puzon-McLaughlin W, Lafuente EM, Boussiotis VA, Shattil SJ, Ginsberg MH (2006) Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 16:1796–1806
Harper MT, Poole AW (2010) Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 8:454–462
Hers I (2007) Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kalpha pathway. Blood 110:4243–4252
Herter JM, Rossaint J, Zarbock A (2014) Platelets in inflammation and immunity. J Thromb Haemost 12:1764–1775
Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, Wymann M, Montrucchio G (2001) Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15:2019–2021
Horii K, Kahn ML, Herr AB (2006) Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood 108:936–942
Huang J, Roth R, Heuser JE, Sadler JE (2009) Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood 113:1589–1597
Hughes CE, Pollitt AY, Mori J, Eble JA, Tomlinson MG, Hartwig JH, O’Callaghan CA, Futterer K, Watson SP (2010) CLEC-2 activates Syk through dimerization. Blood 115:2947–2955
Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P (2002) Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 297:1176–1179
Hynes R (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673–687
Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP (2006) Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood 107:1405–1412
Inoue O, Hokamura K, Shirai T, Osada M, Tsukiji N, Hatakeyama K, Umemura K, Asada Y, Suzuki-Inoue K, Ozaki Y (2015) Vascular smooth muscle cells stimulate platelets and facilitate thrombus formation through platelet CLEC-2: implications in atherothrombosis. PLoS One 10:e0139357
Iwamoto DV, Calderwood DA (2015) Regulation of integrin-mediated adhesions. Curr Opin Cell Biol 36:41–47
Jackson SP (2007) The growing complexity of platelet aggregation. Blood 109:5087–5095
Jarvis GE, Bihan D, Hamaia S, Pugh N, Ghevaert CJ, Pearce AC, Hughes CE, Watson SP, Ware J, Rudd CE, Farndale RW (2012) A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2)β(1). J Thromb Haemost 10:268–277
Jarvis GE, Humphries RG, Robertson MJ, Leff P (2000) ADP can induce aggregation of human platelets via both P2Y(1) and P(2T) receptors. Br J Pharmacol 129:275–282
Jirouskova M, Jaiswal JK, Coller BS (2007) Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading. Blood 109:5260–5269
Jones CI, Garner SF, Moraes LA, Kaiser WJ, Rankin A, Bloodomics C, Ouwehand WH, Goodall AH, Gibbins JM (2009) PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett 583:3618–3624
Jones CI, Barrett NE, Moraes LA, Gibbins JM, Jackson DE (2012) Endogenous inhibitory mechanisms and the regulation of platelet function. Methods Mol Biol 788:341–366
Jones S, Evans RJ, Mahaut-Smith MP (2014) Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation. Mol Pharmacol 86:243–251
Jung SM, Moroi M, Soejima K, Nakagaki T, Miura Y, Berndt MC, Gardiner EE, Howes JM, Pugh N, Bihan D et al (2012) Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem 287:30000–30013
Kahner BN, Kato H, Banno A, Ginsberg MH, Shattil SJ, Ye F (2012) Kindlins, integrin activation and the regulation of talin recruitment to alphaIIbbeta3. PLoS One 7:e34056
Kapur R, Zufferey A, Boilard E, Semple JW (2015) Nouvelle cuisine: platelets served with inflammation. J Immunol 194:5579–5587
Kasirer-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, Shattil SJ (2004) Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood 103:3403–3411
Kasirer-Friede A, Moran BP, Nagrampa-Orje J, Swanson K, Ruggeri ZM, Schraven B, Neel B, Koretzky G, Shattil SJ (2006) ADAP is involved in activation of αIIbβ3 by VWF/GP Ib-IX-V and other agonists. Blood. doi:10.1182/blood-2006-05-022301
Kasirer-Friede A, Kahn ML, Shattil SJ (2007) Platelet integrins and immunoreceptors. Immunol Rev 218:247–264
Kasirer-Friede A, Ruggeri ZM, Shattil SJ (2010) Role for ADAP in shear flow-induced platelet mechanotransduction. Blood 115:2274–2282
Kasirer-Friede A, Kang J, Kahner B, Ye F, Ginsberg MH, Shattil SJ (2014) ADAP interactions with talin and kindlin promote platelet integrin alphaIIbbeta3 activation and stable fibrinogen binding. Blood 123:3156–3165
Kauffenstein G, Bergmeier W, Eckly A, Ohlmann P, Leon C, Cazenave JP, Nieswandt B, Gachet C (2001) The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin—a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett 505:281–290
Kaywin P, McDonough M, Insel PA, Shattil SJ (1978) Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med 299:505–509
Kim C, Schmidt T, Cho EG, Ye F, Ulmer TS, Ginsberg MH (2011) Basic amino-acid side chains regulate transmembrane integrin signaling. Nature 481:209–213
Kuijpers TW, van de Vijver E, Weterman MA, de Boer M, Tool AT, van den Berg TK, Moser M, Jakobs ME, Seeger K, Sanal O et al (2009) LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 113:4740–4746
Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20:576–590
Lafuente EM, van Puijenbroek AA, Krause M, Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA, Gertler FB, Boussiotis VA (2004) RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell 7:585–595
Larson MK, Chen H, Kahn ML, Taylor AM, Fabre JE, Mortensen RM, Conley PB, Parise LV (2003) Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood 101:1409–1415
Lau TL, Kim C, Ginsberg MH, Ulmer TS (2009) The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J 28:1351–1361
Laurent PA, Severin S, Gratacap MP, Payrastre B (2014) Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1. Adv Biol Regul 54:162–174
Lecut C, Schoolmeester A, Kuijpers MJ, Broers JL, van Zandvoort MA, Vanhoorelbeke K, Deckmyn H, Jandrot-Perrus M, Heemskerk JW (2004) Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol 24:1727–1733
Lee HS, Lim CJ, Puzon-McLaughlin W, Shattil SJ, Ginsberg MH (2009) RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol Chem 284:5119–5127
Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J Clin Invest 104:1731–1737
Levin C, Koren A, Pretorius E, Rosenberg N, Shenkman B, Hauschner H, Zalman L, Khayat M, Salama I, Elpeleg O, Shalev S (2015) Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small-platelet thrombocytopenia. J Thromb Haemost 13:1285–1292
Li R, Emsley J (2013) The organizing principle of the platelet glycoprotein Ib-IX-V complex. J Thromb Haemost 11:605–614
Liu J, Das M, Yang J, Ithychanda SS, Yakubenko VP, Plow EF, Qin J (2015a) Structural mechanism of integrin inactivation by filamin. Nat Struct Mol Biol 22:383–389
Liu J, Wang Z, Thinn AM, Ma YQ, Zhu J (2015b) The dual structural roles of the membrane distal region of the alpha-integrin cytoplasmic tail during integrin inside-out activation. J Cell Sci 128:1718–1731
Lorenz V, Stegner D, Stritt S, Vogtle T, Kiefer F, Witke W, Schymeinsky J, Watson SP, Walzog B, Nieswandt B (2015) Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization. Blood 125:4069–4077
Lova P, Guidetti GF, Canobbio I, Catricala S, Balduini C, Torti M (2011) Epinephrine-mediated protein kinase C and Rap1b activation requires the co-stimulation of Gz-, Gq-, and Gi-coupled receptors. Thromb Haemost 105:479–486
Luo BH, Carman CV, Springer TA (2007) Structural basis of integrin regulation and signaling. Annu Rev Immunol 25:619–647
Malinin NL, Zhang L, Choi J, Ciocea A, Razorenova O, Ma YQ, Podrez EA, Tosi M, Lennon DP, Caplan AI et al (2009) A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 15:313–318
Malinin NL, Plow EF, Byzova TV (2010) Kindlins in FERM adhesion. Blood 115:4011–4017
Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C et al (2015) Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 126:683–691
Manne BK, Badolia R, Dangelmaier C, Eble JA, Ellmeier W, Kahn M, Kunapuli SP (2015) Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets. J Biol Chem 290:11557–11568
Marcus AJ, Broekman MJ, Drosopoulos JH, Olson KE, Islam N, Pinsky DJ, Levi R (2005) Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 31:234–246
Martinod K, Wagner DD (2014) Thrombosis: tangled up in NETs. Blood 123:2768–2776
McCarty OJ, Zhao Y, Andrew N, Machesky LM, Staunton D, Frampton J, Watson SP (2004) Evaluation of the role of platelet integrins in fibronectin-dependent spreading and adhesion. J Thromb Haemost 2:1823–1833
McFadyen JD, Kaplan ZS (2015) Platelets are not just for clots. Transfus Med Rev 29:110–119
Meyer Dos Santos S, Blankenbach K, Scholich K, Dorr A, Monsefi N, Keese M, Linke B, Deckmyn H, Nelson K, Harder S (2015) Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall. Thromb Haemost 114:297–312
Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS (1991) Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood 77:770–779
Min SH, Abrams CS (2013) Regulation of platelet plug formation by phosphoinositide metabolism. Blood 122:1358–1365
Miyata S, Goto S, Federici AB, Ware J, Ruggeri ZM (1996) Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha. J Biol Chem 271:9046–9053
Moncada S, Vane JR (1981) Prostacyclin: its biosynthesis, actions and clinical potential. Philos Trans R Soc Lond B Biol Sci 294:305–329
Mori J, Pearce AC, Spalton JC, Grygielska B, Eble JA, Tomlinson MG, Senis YA, Watson SP (2008) G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem 283:35419–35427
Moroi AJ, Watson SP (2015) Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3alpha/beta. J Thromb Haemost 13:1139–1150
Moscardo A, Valles J, Latorre A, Jover R, Santos MT (2015) The histone deacetylase sirtuin 2 is a new player in the regulation of platelet function. J Thromb Haemost 13:1335–1344
Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R (2008) Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 14:325–330
Moser M, Bauer M, Schmid S, Ruppert R, Schmidt S, Sixt M, Wang HV, Sperandio M, Fassler R (2009a) Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med 15:300–305
Moser M, Legate KR, Zent R, Fassler R (2009b) The tail of integrins, talin, and kindlins. Science 324:895–899
Murugappan S, Shankar H, Bhamidipati S, Dorsam RT, Jin J, Kunapuli SP (2005) Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets. Blood 106:550–557
Naseem KM, Riba R (2008) Unresolved roles of platelet nitric oxide synthase. J Thromb Haemost 6:10–19
Nash CA, Severin S, Dawood BB, Makris M, Mumford A, Wilde J, Senis YA, Watson SP (2010) Src family kinases are essential for primary aggregation by G(i)—coupled receptors. J Thromb Haemost 8:2273–2282
Nayak MK, Kumar K, Dash D (2011) Regulation of proteasome activity in activated human platelets. Cell Calcium 49:226–232
Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD (2000) Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106:385–392
Nieswandt B, Watson SP (2003) Platelet collagen interaction: is GPVI the central receptor? Blood 102:449–461
Nurden P, Savi P, Heilmann E, Bihour C, Herbert JM, Maffrand JP, Nurden A (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 95:1612–1622
O’Brien KA, Stojanovic-Terpo A, Hay N, Du X (2011) An important role for Akt3 in platelet activation and thrombosis. Blood 118:4215–4223
O’Donnell VB, Murphy RC, Watson SP (2014) Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circ Res 114:1185–1203
Offermanns S (2006) Activation of platelet function through G protein-coupled receptors. Circ Res 99:1293–1304
Ozaki Y, Suzuki-Inoue K, Inoue O (2013) Platelet receptors activated via multimerization: glycoprotein VI, GPIb-IX-V, and CLEC-2. J Thromb Haemost 11(Suppl 1):330–339
Park EJ, Yuki Y, Kiyono H, Shimaoka M (2015) Structural basis of blocking integrin activation and deactivation for anti-inflammation. J Biomed Sci 22:51
Paul BZ, Jin J, Kunapuli SP (1999) Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 274:29108–29114
Petrich BG, Marchese P, Ruggeri ZM, Spiess S, Weichert RA, Ye F, Tiedt R, Skoda RC, Monkley SJ, Critchley DR, Ginsberg MH (2007) Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 204:3103–3111
Phillips DR, Agin PP (1977) Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. Biochem Biophys Res Commun 75:940–947
Plow EF, McEver RP, Coller BS, Woods VLJ, Marguerie GA, Ginsberg MH (1985) Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets. Blood 66:724–727
Plow EF, Meller J, Byzova TV (2014) Integrin function in vascular biology: a view from 2013. Curr Opin Hematol 21:241–247
Pluskota E, Woody NM, Szpak D, Ballantyne CM, Soloviev DA, Simon DI, Plow EF (2008) Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood 112:2327–2335
Pula G, Crosby D, Baker J, Poole AW (2005) Functional interaction of protein kinase Calpha with the tyrosine kinases Syk and Src in human platelets. J Biol Chem 280:7194–7205
Qiao JL, Shen Y, Gardiner EE, Andrews RK (2010) Proteolysis of platelet receptors in humans and other species. Biol Chem 391:893–900
Qu H, Tu Y, Guan JL, Xiao G, Wu C (2014) Kindlin-2 Tyrosine Phosphorylation and Interaction with Src Serve as a Regulatable Switch in the Integrin Outside-in Signaling Circuit. J Biol Chem 289:31001–31013
Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B (2007) Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 110:529–535
Raslan Z, Naseem KM (2014) The control of blood platelets by cAMP signalling. Biochem Soc Trans 42:289–294
Ratnikov B, Ptak C, Han J, Shabanowitz J, Hunt DF, Ginsberg MH (2005) Talin phosphorylation sites mapped by mass spectrometry. J Cell Sci 118:4921–4923
Rittenhouse SE (1996) Phosphoinositide 3-kinase activation and platelet function. Blood 88:4401–4414
Roberts GC, Critchley DR (2009) Structural and biophysical properties of the integrin-associated cytoskeletal protein talin. Biophys Rev 1:61–69
Rollini F, Franchi F, Angiolillo DJ (2015) Switching P2Y-receptor inhibitors in patients with coronary artery disease. Nat Rev Cardiol 13:11–27
Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227–1234
Ruggeri ZM, Mendolicchio GL (2007) Adhesion mechanisms in platelet function. Circ Res 100:1673–1685
Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C (1978) Prostaglandins and thromboxanes. Annu Rev Biochem 47:997–1029
Savage B, Shattil SJ, Ruggeri ZM (1992) Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 267:11300–11306
Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289–297
Schaff M, Tang C, Maurer E, Bourdon C, Receveur N, Eckly A, Hechler B, Arnold C, de Arcangelis A, Nieswandt B et al (2013) Integrin alpha6beta1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation 128:541–552
Schattner M (2014) Platelets and galectins. Ann Transl Med 2:85
Schattner M, Rabinovich GA (2013) Galectins: new agonists of platelet activation. Biol Chem 394:857–863
Schechtman D, Mochly-Rosen D (2001) Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20:6339–6347
Schubert S, Weyrich AS, Rowley JW (2014) A tour through the transcriptional landscape of platelets. Blood 124:493–502
Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, Esmon CT (2011) Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118:1952–1961
Shattil SJ, Kim C, Ginsberg MH (2010) The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 11:288–300
Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE (1996) Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 88:2939–2950
Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA (2000) Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192:193–204
Simon AY, Sutherland MR, Pryzdial EL (2015) Dengue virus binding and replication by platelets. Blood 126:378–385
Smolenski A (2012) Novel roles of cAMP/cGMP-dependent signaling in platelets. J Thromb Haemost 10:167–176
Soriani A, Moran B, de Virgilio M, Kawakami T, Altman A, Lowell C, Eto K, Shattil SJ (2006) A role for PKCtheta in outside-in alpha(IIb)beta3 signaling. J Thromb Haemost 4:648–655
Srinivasan S, Schiemer J, Zhang X, Chishti AH, Le Breton GC (2015) Galpha13 switch region 2 binds to the Talin head domain and activates alphaIIbbeta3 integrin in human platelets. J Biol Chem 290:25129–25139
Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF (2013) Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 121:1875–1885
Stefanini L, Paul DS, Robledo RF, Chan ER, Getz TM, Campbell RA, Kechele DO, Casari C, Piatt R, Caron KM et al (2015) RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest 125:1419–1432
Strehl A, Munnix IC, Kuijpers MJ, van der Meijden PE, Cosemans JM, Feijge MA, Nieswandt B, Heemskerk JW (2007) Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets. J Biol Chem 282:7046–7055
Stritt S, Wolf K, Lorenz V, Vogtle T, Gupta S, Bosl MR, Nieswandt B (2015) Rap1-GTP-interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice. Blood 125:219–222
Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, Moser M, Metin A, Fried M, Tomlinson I, Hogg N (2009) Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 15:306–312
Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM (1998) Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102:1994–2001
Truong T, Shams H, Mofrad MR (2015) Mechanisms of integrin and filamin binding and their interplay with talin during early focal adhesion formation. Integr Biol (Camb) 7:1285–1296
Varga-Szabo D, Pleines I, Nieswandt B (2008) Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28:403–412
Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE (1996) Analysis of GP IIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 88:907–914
Wang JH (2012) Pull and push: talin activation for integrin signaling. Cell Res 22:1512–1514
Wang H, Rudd CE (2008) SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesion. Trends Cell Biol 18:486–493
Watanabe N, Bodin L, Pandey M, Krause M, Coughlin S, Boussiotis VA, Ginsberg MH, Shattil SJ (2008) Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin aIIbb3. J Cell Biol 181:1211–1222
Watson SP, Lowe K, Finney BA (2014) Platelets in lymph vessel development and integrity. Adv Anat Embryol Cell Biol 214:93–105
Wegener KL, Partridge AW, Han J, Pickford AR, Liddington RC, Ginsberg MH, Campbell ID (2007) Structural basis of integrin activation by talin. Cell 128:171–182
Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J (1982) Pseudo-von Willebrand’s disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 306:326–333
Weksler BB (1982) Prostacyclin. Prog Hemost Thromb 6:113–138
Wickham TJ, Mathias P, Cheresh DA, Nemerow GR (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309–319
Woods VL, Wolff LE, Keller DM (1986) Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem 261:15242–15251
Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF (2004) Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 113:441–450
Xiao T, Takagi J, Coller BS, Wang JH, Springer TA (2004) Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432:59–67
Ye F, Hu G, Taylor D, Ratnikov B, Bobkov AA, McLean MA, Sligar SG, Taylor KA, Ginsberg MH (2010) Recreation of the terminal events in physiological integrin activation. J Cell Biol 188:157–173
Ye F, Petrich BG, Anekal P, Lefort CT, Kasirer-Friede A, Shattil SJ, Ruppert R, Moser M, Fassler R, Ginsberg MH (2013) The mechanism of kindlin-mediated activation of integrin alphaIIbbeta3. Curr Biol 23:2288–2295
Ye F, Snider AK, Ginsberg MH (2014) Talin and kindlin: the one-two punch in integrin activation. Front Med 8:6–16
Yeung J, Apopa PL, Vesci J, Kenyon V, Rai G, Jadhav A, Simeonov A, Holman TR, Maloney DJ, Boutaud O, Holinstat M (2012) Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation. Mol Pharmacol 81:420–430
Zhang J, Shattil SJ, Cunningham MC, Rittenhouse SE (1996) Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin. J Biol Chem 271:6265–6272
Zhang W, Deng W, Zhou L, Xu Y, Yang W, Liang X, Wang Y, Kulman JD, Zhang XF, Li R (2015) Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex. Blood 125:562–569
Zhu J, Zhu J, Negri A, Provasi D, Filizola M, Coller BS, Springer TA (2010) Closed headpiece of integrin alphaIIbbeta3 and its complex with an alphaIIbbeta3-specific antagonist that does not induce opening. Blood 116:5050–5059
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kasirer-Friede, A., Shattil, S.J. (2017). Regulation of Platelet Adhesion Receptors. In: Gresele, P., Kleiman, N., Lopez, J., Page, C. (eds) Platelets in Thrombotic and Non-Thrombotic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-47462-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-47462-5_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47460-1
Online ISBN: 978-3-319-47462-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)